Jerusalem, Israel - March 9, 2025  - The MIXiii HealthTech conference held in the International Conference Center in Jerusalem, Israel, on March 4-5, 2025, was a testament to Israel’s unwavering innovation spirit, despite the challenges faced in recent times. 

Israel is still reeling from the effects of war, however, this year saw an impressive turnout of 1,700 professionals, including representatives from Teva, Philips, the U.S. embassy, and delegations from the Czech Republic. 

As in the past, Yissum, the technology transfer company of the Hebrew University of Jerusalem, had a significant presence at the event. The Yissum exhibition booth activity reflected the global interest in Israeli research and technology.

“We have truly seen that the innovation spirit didn’t stop,” says Tamar Vogel, Marketing & Communications Department Manager at Yissum. “Our researchers kept pushing forward, recognizing that research and solutions to build a better future are not just essential for survival but are also the driving force behind Israel’s economic resilience.  MIXiii provided a great forum to make new connections, strengthening relationships with investors from multinational companies who continue to see the value in Israeli innovation,” she added.

Alon Natanson, Yissum’s newly appointed CEO, introduced a panel titled Trailblazing Innovations Emerging from Israeli Academia & Hospitals, highlighting groundbreaking research from Israel’s top institutions. Yissum itself marked an impressive year, celebrating 61 years of innovation with the launch of 14 new startups, 97 new patents filed, 21 new license agreements, and 97 Sponsored Research & Services Agreements. This milestone coincides with the Hebrew University’s 100th anniversary, making it even more special to showcase Yissum’s deep involvement in the innovation ecosystem and the pride they take in being an integral part of Jerusalem’s legacy of excellence.

One success story from Yissum-backed startups is Salignostics, a company originally founded to develop saliva-based COVID-19 testing, based on the research of Prof. Aaron Palmon. Today, its Salistick technology is revolutionizing pregnancy testing with a non-invasive, saliva-based solution and is being further explored in partnerships with Sheba Hospital to detect oral cancer. The innovation doesn’t stop there—Salignostics’ technology is now being tested in Ethiopia for HIV detection.

Another Yissum success story is MaxSum Seeds, founded by Prof. Zvi Peleg, which cultivated hectares of sesame fields across Argentina and Brazil. The company now also produces some of the purest honey on the market, alongside its sesame-based products. For social justice efforts, MaxSum Seeds also pioneered helping recultivate fields in Southern Israel after October 7th

These examples illustrate how Yissum and Israeli innovation continue to attract global attention and investment, driving cutting-edge advancements that impact industries and improve lives worldwide.